Osteoinductive Molecules in Orthopaedics: Basic Science and Preclinical Studies

Osteoinductive molecules are characterized by their ability to promote the formation of bone. Most osteoinductive molecules are cytokines, which are extracellular proteins or peptides that mediate cell to cell signaling. Examples of osteoinductive cytokines are certain bone morphogenetic proteins and some growth and differentiation factors. Some osteoinductive molecules are not secreted molecules. LIM mineralization protein-1 is an example of an intracellular osteoinductive molecule. Significant advances have been made in characterizing the molecular composition and mechanism of action of these osteoinductive molecules. Preclinical studies with these molecules have provided better understanding of the doses, formulation, and delivery mechanism necessary for effective bone formation in model systems of spinal fusion and other orthopaedic problems. The current authors will review the most important basic science and preclinical studies involving these osteoinductive molecules.

[1]  W. Hutton,et al.  Adenoviral Delivery of LIM Mineralization Protein-1 Induces New-Bone Formation in Vitro and in Vivo , 2001, The Journal of bone and joint surgery. American volume.

[2]  L. Titus,et al.  Gene therapy for spine fusion. , 2000, Clinical orthopaedics and related research.

[3]  Linshu Liu,et al.  Inductive activity of recombinant human growth and differentiation factor-5. , 2000, Biochemical Society transactions.

[4]  M. Ito,et al.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.

[5]  K. Miyazono,et al.  Positive and negative regulation of TGF-beta signaling. , 2000, Journal of cell science.

[6]  A. Linde,et al.  Effects of recombinant human fibroblast growth factor-2 on osteogenic cell populations during orthopic osteogenesis in vivo. , 2000, Bone.

[7]  J. Heckman,et al.  Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. , 1999, The Journal of bone and joint surgery. American volume.

[8]  L. Titus,et al.  Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. , 1999, Spine.

[9]  R. F. Morgan,et al.  Repair of a Rodent Nasal Critical‐Size Osseous Defect With Osteoblast Augmented Collagen Gel , 1999, The Laryngoscope.

[10]  J. Andrades,et al.  A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells. , 1999, Experimental cell research.

[11]  J. Poser,et al.  Novel formulation of fibroblast growth factor‐2 in a hyaluronan gel accelerates fracture healing in nonhuman primates , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  A Daluiski,et al.  The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. , 1999, The Journal of bone and joint surgery. American volume.

[13]  S. Boden,et al.  Posterolateral Lumbar Intertransverse Process Spine Arthrodesis With Recombinant Human Bone Morphogenetic Protein 2/Hydroxyapatite‐Tricalcium Phosphate After Laminectomy in the Nonhuman Primate , 1999, Spine.

[14]  J. Fischgrund,et al.  The Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP‐2) to Promote Spinal Fusion in a Nonhuman Primate Anterior Interbody Fusion Model , 1999, Spine.

[15]  L. Titus,et al.  New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. , 1999, Spine.

[16]  B. Cunningham,et al.  Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine. A comparative endoscopic study using the Bagby and Kuslich interbody fusion device. , 1999, Spine.

[17]  W. Hutton,et al.  The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. , 1999, Spine.

[18]  J. Lou,et al.  Gene therapy: Adenovirus‐mediated human bone morphogenetic protein‐2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[19]  M. Matzuk,et al.  The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. , 1998, Molecular endocrinology.

[20]  D. Hu,et al.  LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. , 1998, Endocrinology.

[21]  L. Titus,et al.  1998 Volvo Award Winner in Basic Science Studies: Lumbar Spine Fusion by Local Gene Therapy With a cDNA Encoding a Novel Osteoinductive Protein (LMP‐1) , 1998, Spine.

[22]  M. Maeda,et al.  Continuous Administration of Basic Fibroblast Growth Factor (FGF-2) Accelerates Bone Induction on Rat Calvaria— An Application of a New Drug Delivery System , 1998, Journal of dental research.

[23]  L. Titus,et al.  Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2 , 1998 .

[24]  E. Canalis,et al.  Insulin-like growth factor II promoter expression in cultured rodent osteoblasts and adult rat bone. , 1998, Endocrinology.

[25]  G. Finerman,et al.  Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[26]  M. Markel,et al.  Cervical Interbody Fusion Cages: An Animal Model With and Without Bone Morphogenetic Protein , 1998, Spine.

[27]  H. Tesluk,et al.  Effect of insulin-like growth factor type I on critical size calvarial bone defects in irradiated rats. , 1998, The Journal of craniofacial surgery.

[28]  D. Silcox,et al.  Reversing the Inhibitory Effect of Nicotine on Spinal Fusion Using an Osteoinductive Protein Extract , 1998, Spine.

[29]  S. Boden,et al.  Experimental Posterolateral Lumbar Spinal Fusion With a Demineralized Bone Matrix Gel , 1998, Spine.

[30]  S. Boden,et al.  Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. , 1997, Journal of spinal disorders.

[31]  A. Patwardhan,et al.  Tibial segmental defect repair: Chondrogenesis and biomechanical strength modulated by basic fibroblast growth factor , 1997, The Anatomical record.

[32]  S. Harris,et al.  Bone Morphogenetic Protein 2 (BMP-2) Enhances BMP-3, BMP-4, and Bone Cell Differentiation Marker Gene Expression During the Induction of Mineralized Bone Matrix Formation in Culturesof Fetal Rat Calvarial Osteoblasts , 1997, Calcified Tissue International.

[33]  S. Mohan,et al.  Osteogenic Protein-1 Stimulates mRNA Levels of BMP-6 and Decreases mRNA Levels of BMP-2 and -4 in Human Osteosarcoma Cells , 1997, Calcified Tissue International.

[34]  S. Boden,et al.  Video‐Assisted Lateral Intertransverse Process Arthrodesis: Validation of a New Minimally Invasive Lumbar Spinal Fusion Technique in the Rabbit and Nonhuman Primate (Rhesus) Models , 1996, Spine.

[35]  R. Delamarter,et al.  Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.

[36]  W. Hutton,et al.  Morphology of the lumbar intertransverse process fusion mass in the rabbit model: a comparison between two bone graft materials--rhBMP-2 and autograft. , 1996, Journal of spinal disorders.

[37]  K. Lyons,et al.  Bone morphogenetic protein-2: biology and applications. , 1996, Clinical orthopaedics and related research.

[38]  J. Michael Kabo,et al.  Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.

[39]  W. Hutton,et al.  Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.

[40]  H. Tesluk,et al.  Effect of Insulin‐Like Growth Factor Type 1 on Critical‐Size Defects in Diabetic Rats , 1995, The Journal of craniofacial surgery.

[41]  S. Cook,et al.  In Vivo Evaluation of Recombinant Human Osteogenic Protein (rhOP-1) Implants As a Bone Graft Substitute for Spinal Fusions , 1994, Spine.

[42]  N. Copeland,et al.  Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily , 1994, Nature.

[43]  S. Frenkel,et al.  Demineralized Bone Matrix: Enhancement of Spinal Fusion , 1993, Spine.

[44]  V. Rosen,et al.  The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.

[45]  T. Lindholm,et al.  Interaction of allogeneic demineralized bone matrix and porous hydroxyapatite bioceramics in lumbar interbody fusion in rabbits. , 1991, Clinical orthopaedics and related research.

[46]  E. Wang,et al.  Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. , 1991, Archives of otolaryngology--head & neck surgery.

[47]  M. Urist,et al.  Augmentation of spinal fusion with bone morphogenetic protein in dogs. , 1989, Clinical orthopaedics and related research.

[48]  T S Lindholm,et al.  Response of bone marrow stroma cells to demineralized cortical bone matrix in experimental spinal fusion in rabbits. , 1988, Clinical orthopaedics and related research.

[49]  M. Urist,et al.  Bone cell differentiation and growth factors. , 1983, Science.

[50]  K. Takagi,et al.  The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. , 1982, Clinical orthopaedics and related research.

[51]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[52]  W. Bristow Arthrodesis , 1927, British medical journal.

[53]  D. Kallmes,et al.  Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. , 1999, Journal of neurosurgery.

[54]  B. Hogan,et al.  Mice lacking Bmp6 function. , 1998, Developmental genetics.

[55]  V. Rosen,et al.  Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. , 1996, Growth factors.

[56]  R. Balling,et al.  Analysis of limb patterning in BMP-7-deficient mice. , 1996, Developmental genetics.